Target Name: LOC101928195
NCBI ID: G101928195
Review Report on LOC101928195 Target / Biomarker Content of Review Report on LOC101928195 Target / Biomarker
LOC101928195
Other Name(s): methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like pseudogene | Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like pseudogene

Exploring LOC101928195: A Pseudogene associated with MDH1 Enzyme

Exploring the Potential Drug Target LOC101928195: A Pseudogene for Methylenetetrahydrofolate Dehydrogenase (NADP+-Dependent) 1

LOC101928195 is a pseudogene associated with methylenetetrahydrofolate dehydrogenase (NADP+-dependent) 1 (MDH1), a crucial enzyme in the folate cycle that converts methylenetetrahydrofolate (MEHF) to namealenetetrahydrofolate (NADPH). This pseudogene has been identified using next-generation sequencing (NGS) and is located on chromosome 19 at position 5.

Several studies have suggested that LOC101928195 may be a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will explore the potential drug target significance of LOC101928195 and its potential as a biomarker for disease diagnosis and treatment.

Potential Drug Target

The identification of LOC101928195 as a pseudogene associated with MDH1 highlights its potential as a drug target. MDH1 is a key enzyme in the folate cycle, and its dysfunction has been implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In cancer, MDH1 has been shown to be involved in the regulation of cell growth, apoptosis, and angiogenesis. Several studies have shown that inhibition of MDH1 has anticancer effects, leading to the potential for LOC101928195 as a cancer therapeutic.

In neurodegenerative diseases, MDH1 has been linked to the progression of neurodegeneration. Therefore, targeting MDH1 with drugs that modulate its activity could be a promising strategy for the treatment of neurodegenerative diseases.

In autoimmune disorders, MDH1 has been shown to play a role in the regulation of immune cell function. Therefore, modulating MDH1 activity could be a potential approach for the treatment of autoimmune disorders.

Potential Biomarker

LOC101928195 could also be used as a biomarker for disease diagnosis and monitoring. The detection and quantification of MDH1 activity could be used as a marker for the efficacy of drugs targeting LOC101928195.

Furthermore, LOC101928195 could be used as a biomarker for disease progression and response to treatment. By measuring the levels of MDH1 activity in patient samples before and after treatment, doctors could determine the effectiveness of a drug and monitor its impact on disease progression.

Conclusion

In conclusion, LOC101928195 is a pseudogene associated with MDH1, a crucial enzyme in the folate cycle. The identification of LOC101928195 as a potential drug target or biomarker for various diseases underscores its potential as a therapeutic agent. Further research is needed to determine the full scope of LOC101928195's potential as a drug and to explore its potential as a biomarker for disease diagnosis and treatment.

Protein Name: Methylenetetrahydrofolate Dehydrogenase (NADP+ Dependent) 1 Like Pseudogene

The "LOC101928195 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC101928195 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC101928201 | LOC101928219 | LOC101928230 | LOC101928251 | LOC101928268 | LOC101928269 | LOC101928272 | LOC101928273 | LOC101928274 | LOC101928281 | LOC101928331 | LOC101928334 | LOC101928338 | LOC101928344 | LOC101928347 | LOC101928351 | LOC101928354 | LOC101928371 | LOC101928372 | LOC101928373 | LOC101928381 | LOC101928385 | LOC101928387 | LOC101928391 | LOC101928416 | LOC101928417 | LOC101928423 | LOC101928437 | LOC101928438 | LOC101928446 | LOC101928462 | LOC101928463 | LOC101928495 | LOC101928499 | LOC101928505 | LOC101928510 | LOC101928512 | LOC101928516 | LOC101928524 | LOC101928540 | LOC101928565 | LOC101928570 | LOC101928592 | LOC101928618 | LOC101928621 | LOC101928622 | LOC101928635 | LOC101928663 | LOC101928697 | LOC101928699 | LOC101928704 | LOC101928718 | LOC101928743 | LOC101928760 | LOC101928762 | LOC101928796 | LOC101928804 | LOC101928816 | LOC101928824 | LOC101928832 | LOC101928834 | LOC101928844 | LOC101928847 | LOC101928849 | LOC101928859 | LOC101928861 | LOC101928864 | LOC101928890 | LOC101928893 | LOC101928894 | LOC101928911 | LOC101928912 | LOC101928923 | LOC101928940 | LOC101928947 | LOC101928948 | LOC101928950 | LOC101928972 | LOC101929003 | LOC101929048 | LOC101929073 | LOC101929085 | LOC101929098 | LOC101929106 | LOC101929129 | LOC101929130 | LOC101929133 | LOC101929174 | LOC101929200 | LOC101929208 | LOC101929219 | LOC101929237 | LOC101929256 | LOC101929258 | LOC101929268 | LOC101929279 | LOC101929298 | LOC101929309 | LOC101929372 | LOC101929401